This company has been acquired
Sigilon Therapeutics Dividend
Dividend criteria checks 0/6
Sigilon Therapeutics does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$12.03 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Benign Growth For Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Underpins Stock's 34% Plummet
Apr 17Sigilon Therapeutics GAAP EPS of -$0.44, revenue of $2.88M
Aug 04Sigilon Therapeutics names Philip Ashton-Rickardt as chief scientific officer
Jun 14What Percentage Of Sigilon Therapeutics, Inc. (NASDAQ:SGTX) Shares Do Insiders Own?
Mar 04Sigilon Therapeutics' MPS-1 gene therapy an Orphan Drug in U.S.
Dec 17Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if SGTX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SGTX's dividend payments have been increasing.
Dividend Yield vs Market
Sigilon Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (SGTX) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.9% |
Analyst forecast in 3 Years (SGTX) | n/a |
Notable Dividend: Unable to evaluate SGTX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SGTX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SGTX has not reported any payouts.